VanEck Biotech ETF · $525M$13,077
BBHBBH vsARKGARKGARK Genomic Revolution ETF · $2.2B$6,586
$10,000 five years ago, dividends reinvested · they hold 11.3% in common
BBHMeasureARKG
Returns · dividends reinvested
+35.0%Year to dateJan 1 → Nov 3+70.9%
+41.8%1 yearTotal return+59.0%
+21.8%3 years · per year$10,000 became $18,067 · $22,262+30.6%
+5.5%5 years · per year$10,000 became $13,077 · $6,586−8.0%
Cost and income
0.35%Expense ratio$35 · $75 a year on $10k · lower is better0.75%
0.37%Trailing 12-mo yield$37 · $0 a year on $10k0.00%
Risk · past year
−10.5%Worst dropSmaller is better−27.5%
22.3%VolatilityLower is calmer45.8%
BBHARKG Winner of the row, in its colourEach row: the bigger of the two fills its side
5–3BBH wins
End-of-day Nov 3, 2026 · returns include dividends · 3Y and 5Y figures are per-year returns